Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "drugs." wg kryterium: Temat


Wyświetlanie 1-11 z 11
Tytuł:
Chemiczne aspekty celowanej terapii przeciwnowotworowej II. Połączenia nośnik -lek
Chemical aspects of targeted anticancer therapy II . Bond of carrier to drug
Autorzy:
Werengowska, K. M.
Wiśniewski, M.
Terzyk, A.P.
Gurtowska, N.
Drewa, T. A.
Olkowska, J.
Powiązania:
https://bibliotekanauki.pl/articles/172570.pdf
Data publikacji:
2012
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
nanonośniki leków
leki przeciwnowotworowe
wiązania kowalencyjne
adsorpcja
nanocarriers of drugs
anticancer drugs
covalent bonds
adsorption
Opis:
Traditional anticancer therapy is usually low effective. Popular and common drugs applied in anticancer therapy are characterized by low solubility and nonspecific biodistribution in an organism. The chemotherapy kills not only cancer but also healthy cells [4]. Building of modern drug delivery systems based on nanocarriers is a new method of anticancer treatment. The present study is directed towards nanomaterials (as carbon nanotubes, liposomes, polymeric micelles) as modern drug carriers. Thus, we characterized mechanisms of actions of traditional chemotherapeutics: paclitaxel, cisplatin and doxorubicin (Figs. 3–5) [1, 15, 21]. The purpose of this study is a description of the bioconjugation of drug-nanocarrier. Chemotherapeutics can be connected to external or internal surfaces of nanocarriers (Fig. 6) [6]. We described two main methods of drug delivery from internal space of nanocarriers: nanoextraction and nanocondensation (Fig. 7) [32]. The type of drug-carrier bonding can be covalent or noncovalent. We report recent advances in the field showing the formation of esters (Figs. 10–11) [28, 29, 53, 54], acethylhydrazone (Fig. 12) [55–61], amides [62–64], and disulfides groups [12, 65]. These reactions depend on functional groups in structures of drugs and require suitable modification of nanocarrier surfaces. In practice, the functionalization of nanocarrier surface is associated with the covering with polymers including PE G, HPMA, PG and PL GA [3]. Adsorption is the most popular process of bonding chemotherapeutic and nanomaterials (Fig. 13) [66]. Special attention is paid to electrostatic interaction between drugs: paclitaxel [74], cisplatin [59, 76, 77], doxorubicin [67–73] and nanocarriers: carbon nanotubes and/or polymeric micells. By application of modern anticancer therapy, drugs are preserved from lysosomal degradation and to fast reaction in biological environment. Finally, nanocarriers improve adsorption of drug and increase concentration of drug only in cancer tissues [6, 7].
Źródło:
Wiadomości Chemiczne; 2012, 66, 7-8; 637-670
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Nowe substancje psychoaktywne : katynon i jego pochodne
New psychoactive substances : cathinone and its derivatives
Autorzy:
Kurpet, Katarzyna
Chwatko, Grażyna
Powiązania:
https://bibliotekanauki.pl/articles/172450.pdf
Data publikacji:
2019
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
katynon
alkaloidy
narkotyki
czuwaliczka jadalna
nowe substancje psychoaktywne
dopalacze
cathinone
alcaloids
drugs
khat
new psychoactive substances
designer drugs
Opis:
Cathinone is the major alkaloid found in the Catha edulis plant. The chemical structure of the cathinone is similar to amphetamine, and the difference in their structure is the presence of the ketone group in the beta side chain position. Synthetic derivatives belong to the novel group of psychoactive substances called “legal highs” or designer drugs. Synthetic cathinones are formed by modifications of the cathinone molecule consisting in the attachment of various substituents to the benzene ring and side chain and the use of a nitrogen atom to build the pyrrolidine ring. On this basis, these relationships can be divided into four main groups: N-alkylated, N-pyrrolidinyl, 3,4-methylenedioxy-N-alkylated and 3,4- methylenedioxy-N-pyrrolidinyl derivatives [1-2]. The simplicity of the synthesis and the availability of substrates favors the continuous process of modifying the cathinone derivatives covered by legal control. Therefore, continuous improvement of cathinone detection methods is extremely important for forensic chemistry. Cathinones easily penetrate the blood-brain barrier, inhibiting the uptake of neurotransmitters, including dopamine, serotonin or noradrenaline, and increase their concentration in the synaptic cleft. This leads to increased monoaminergic transmission in the central as well as in the peripheral nervous system, which entails a number of adverse effects [3]. In this article we described the pharmacokinetics, postulated neurochemical mechanisms and pharmacological and toxicological effects of cathinones. The current legal status of cathinone derivatives and selected synthesis methods was also discussed. We believe these information contribute improving public health and safety.
Źródło:
Wiadomości Chemiczne; 2019, 73, 7-8; 461-489
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Adenozyno-5’-o-(n-acylosulfamoilowe) pochodne jako potencjalne leki przeciwgruźlicze
5’-o-[n-(acyl)sulfamoyl]adenosine derivatives as potential antituberculosis drugs
Autorzy:
Kulik, K.
Baraniak, J.
Powiązania:
https://bibliotekanauki.pl/articles/172072.pdf
Data publikacji:
2016
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
leki przeciwgruźlicze
prątek gruźlicy
acyloadenylany
antituberculosis drugs
Mycobacterium tuberculosis
acyladenylates
Opis:
Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis (TB), is the leading bacterial cause of infectious disease mortality. The current WHOapproved treatment for TB involves a three- or four-drug regimen comprising isoniazid, rifampin, pyrazinamide, and/or ethambutol for a minimum of 6 months. While these first-line agents remain useful in treating susceptible Mycobacterium tuberculosis strains, the emergence of multidrug resistant tuberculosis demands the development of new drugs [1]. Iron acquisition is an essential process for M. tuberculosis as well as almost all other microorganisms. However, this essential micronutrient is highly sequestered in a mammalian host. In response to iron starvation, Mtb produces small-molecule iron chelators, a pair of related peptidic siderophores known as mycobactin and carboxymycobactins that vary by the appended lipid residue termed siderophores [4, 5, 7, 8]. Because mycobactins are critical for growth and virulence of M. tuberculosis, they have emerged as attractive targets for the development of anti-TB agents [4]. Biosynthesis of mycobactin is initiated by the aryl acid adenylation enzyme MbtA which activates salicylic acid forming an acyladenylate intermediate (Sal- AMP). MbtA is also responsible for loading the acyladenylate intermediate onto the thiolation domain of MbtB-SH – the enzyme taking part in the next step of biosynthesis process [10]. Given the documented importance of many siderophores for virulence and lack of human aryl acid adenylation enzymes homologues, several analogues possessing stable linkers as bioisosteres of the labile acyl phosphate function have been synthesized as the potent enzyme inhibitors [13]. The initial lead compound 5’-O-[N- (salicyl)sulfamoyl]adenosine (Sal-AMS) has emerged as a promising inhibitor of MbtA and was shown to possess promising whole-cell activity toward M. tuberculosis.
Źródło:
Wiadomości Chemiczne; 2016, 70, 7-8; 455-472
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Wybrane metody separacyjne i woltamperometryczne w analizie leków i substancji endogennych dla diagnostyki i terapii klinicznej
Selected separation and voltammetric methods in the analysis of drugs and endogenous substances for diagnostics and clinical therapy
Autorzy:
Baranowska, Irena
Bajkacz, Sylwia
Markowski, Piotr
Płonka, Joanna
Powiązania:
https://bibliotekanauki.pl/articles/1413240.pdf
Data publikacji:
2021
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
chromatografia
woltamperometria
leki
aminy biogenne
ekstrakcja
spektrometria
chromatography
voltammetry
drugs
biogenic amines
extraction
spectrometry
Opis:
The developed chromatographic methods (HPLC and UHPLC/UV, DAD, FL, ED, MS-MS and GC-MS), for the determination of drugs from different therapeutic groups in body fluids, have been presented. Drugs were determined alongside their metabolites, in different concentration ranges, usually after a removal of the interferences from the biological material matrix. Extraction procedures, like LLE, SPE, MEPS, SALLE, USAEME, have been developed for the separation of analytes. Methods for the determination of endogenous compounds: L-camitine, L-arginine and their metabolites, dopamine and its metabolites, and other compounds resulting from their metabolism have also been developed. Cyclic voltammetry and differential pulse voltammetry methods for the determination of electrochemically active drugs have also been presented. Such methods can be used to verify the results of chromatographic determinations. This article presents the results of the research included in 35 publications from the JCR list.
Źródło:
Wiadomości Chemiczne; 2021, 75, 7-8; 869-892
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Biblioteki związków chemicznych
Libraries of chemical compounds
Autorzy:
Zwoliński, K. M.
Leśnikowski, Z. J.
Powiązania:
https://bibliotekanauki.pl/articles/172580.pdf
Data publikacji:
2012
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
biblioteka chemiczna
biblioteka wirtualna
przestrzeń chemiczna
związki naturalne
leki
virtual library
chemical library
chemical space
drugs
natural products
Opis:
Over the past decade one can observe a scientific revolution taking place resulting in an explosion of new biotechnologies. Moreover, with the end of the human genome project and following expansion of the extensive genetic research an unprecedented number of new biological targets useful in drug design have been identified. Simultaneously, new methods such as combinatorial synthesis have expanded the overall size of chemical libraries and high-throughtput technologies have enabled to screen more than one million compounds a day [43]. However, an increasing size of chemical libraries in a random fashion may not necessary increase a probability of success and the overall number of successfully identified leads. Thus, success of any drug discovery program depend heavily on the assumed selection criteria of appropriate molecules [58] which properties should maximize the chances of identifying ligands for any given target. Selection criteria used for compounds to generate diverse as well as focused chemical libraries are briefly discussed in the present overview. We describe the most important quality factors such as size, diversity and chemical tractability which should be always kept in mind during the design of chemical libraries. Chemical space is enormous and limited only by a chemist`s imagination. The number of possible drug-like molecules within chemical space has been estimated to be around 1060 [17]. In contrast the overall number of atoms in the observable Universe is approximately 1080. It is obvious that it is impossible to synthesize every possible molecule so one need to explore only those regions of chemical space which are enriched with molecules of appropriate structure and function. Recent strategies for the design of high-quality collections of structurally diverse sets of small molecules are discussed in the context of probing the chemical space in order to find new biologically active structures.
Źródło:
Wiadomości Chemiczne; 2012, 66, 7-8; 741-765
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Enzymatyczne reakcje rozszczepienia wiązania C–C : zastosowanie w syntezie związków zapachowych, farmaceutyków oraz w bioremediacji
Enzymatic reactions of the C–C bond cleavage : applications in synthesis of aroma compounds, pharmaceuticals and in bioremediation
Autorzy:
Panek, A.
Milecka-Tronina, N.
Świzdor, A.
Powiązania:
https://bibliotekanauki.pl/articles/172055.pdf
Data publikacji:
2015
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
β-oksydacja
wanilina
γ-dekalakton
metyloketony
leki steroidowe
bioremediacja
β-oxidation
vanillin
γ-decalactone
methyl ketones
steroid drugs
bioremediation
Opis:
The microorganisms are able to utilize natural and synthetic compounds of broad structural diversity as a source of carbon and energy, converting these substrates into low molecular weight products (mainly H2O, CO2 and NH3). The main role in this metabolism is played by the enzymes that catalyze reactions of the C–C bond cleavage. Such reactions are the key step of the primary metabolism of fatty acids in eukaryotic cells by the β-oxidation. The enzymatic systems associated with the C–C bond cleavage have been applied in the synthesis of valuable natural products and in the bioremediation processes. Microbial transformations of natural compounds, in which the reactions of β-oxidation cycle are used, allow the formation of natural aromatic compounds (used as food additives), pharmaceuticals and ingredients of cosmetic compositions. Using this path one can obtain methyl ketones (e.g. responsible for the characteristic smell of cheeses), γ-lactones determining the scent of several popular fruits, and vanillin. A modification of the natural steroids: saponins, alkaloids, sterols, bile acids to products useful in the synthesis of steroid drugs is the most important area of use of the enzymatic C–C bond cleavage, due to the practical significance of the products. Enzymes that catalyze the C–C bonds cleavage are important in the process of biodegradation of toxic aromatic hydrocarbons and their derivatives (bioremediation).
Źródło:
Wiadomości Chemiczne; 2015, 69, 5-6; 337-368
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Poszukiwanie nowych leków immunosupresyjnych
Quest for new immunosuppressive drugs
Autorzy:
Dzierzbicka, K.
Cholewiński, G.
Iwaszkiewicz-Grześ, D.
Trzonkowski, P.
Powiązania:
https://bibliotekanauki.pl/articles/171863.pdf
Data publikacji:
2011
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
aktywność immunosupresyjna
leki immunosupresyjne
glikokortykosteroidy
takrolimus
CsA
FK506
MPA
kwas mykofenolowy
MMF
MPS
immunosuppressive activity
immunosuppressive drugs
glicocorticosteroids
tacrolimus
Opis:
Transplantology is getting more and more important in medicine. Development of surgical techniques and immunosuppressive treatment enabled to establish successful transplantations with various organs and tissues. However, allografts are recognized as foreign tissues and stimulate rejection, i.e. a strong immunological response which, if not stopped, results in complete destruction of the transplanted tissue. In order to prevent the rejection patients have to be treated with immunosuppressive drugs after transplantation. Unfortunately, such a damping of immune system poses a risk of cancer or severe infections. The treatment itself is also toxic, notably when applied in a long-term maintenance therapy. Currently, adverse effects of immunosuppressive drugs are recognized as the ones to be involved significantly in chronic rejection and limitation of long survival of grafted tissues. Whereas prevention of acute rejection is mostly successful, there is still no efficient treatment for chronic graft rejection. Reduction of a dose of immunosuppressive drugs or an invention of new active substances is considered the most promising solution. Nowadays, immunosuppressive drugs can be divided into the three main groups: agents which inhibit production of cytokines taking part in cells’ activation (glicocorticosteroids, calcineurine inhibitors, mTOR inhibitors), antiproliferative compounds (azathiopirin, mycophenolate mofetil, mycophenolic acid sodium salt), and antibodies. In this article we present new investigations towards immunosuppressive drugs, their structures and synthetic methods.
Źródło:
Wiadomości Chemiczne; 2011, 65, 1-2; 59-92
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Mechanizm oporności na leki platynowe oraz strategie pokonywania tego zjawiska
The mechanism of resistance to platinum drugs and strategies to overcome this phenomenon
Autorzy:
Weiss-Gradzińska, W.
Krzempek, W.
Trynda-Lemiesz, L.
Powiązania:
https://bibliotekanauki.pl/articles/172324.pdf
Data publikacji:
2013
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
leki platynowe
oporność lekowa
leczenie nowotworów
influx
efflux
nanorurki węglowe
cisplatyna
platinum drugs
drug resistance
cancer therapy
carbon nanotubes
cisplatin
Opis:
Platinum drugs belong to one of the oldest [2] and best investigated groups of cytotoxic drugs. On account of their high efficacy and alkylating-like action [14] they are used in a treatment of various types of neoplasms [3–5]. Despite investigators’ best efforts survival time of patients diagnosed with cancer is still short. Responsible for the fact is high toxicity of used therapeutic methods and development of resistance to them [3–5, 19]. In this paper authors review reasons behind decreased sensitivity of neoplastic cells to platinum treatment and discuss the newest promising trends in its overcoming. Due to different properties of neoplastic cells, availability of a chemotherapeutic agent inside a tumour is limited [9–12]. Moreover continuous development of resistance to platinum drugs further decreases their cellular concentration and inactivates their functions. Also owing to increased activity of DNA repair systems, higher tolerance to genome deformations and numerous mechanisms that lead to impaired apoptosis, drug efficacy is reduced [3-5, 19]. In order to increase a potency of platinum agents new therapeutic strategies are investigated. Coadministration with resistance modulators [20, 22, 23] and combination therapy with other antineoplastic drugs [8, 24–30] have already proved their effectiveness. Additionally, newer generations of platinum drugs are developed [15–18]. Mostly platinum(IV) prodrug complexes often releasing axial ligands with their own pharmacological action [5, 6, 31], but also multi-nuclear platinum compounds that form more complex DNA-adducts [32–35]. Other strategies include the development of innovative dosage forms such as single walled carbon nanotubes (SWCNTs), multiwalled carbon nanotubes (MWCNTs) [38, 39] or encapsulation [36, 37]. Finally utilisation of oncolytic viruses could be a way to selectively destroy neoplastically transformed cells [40].
Źródło:
Wiadomości Chemiczne; 2013, 67, 11-12; 1105-1128
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Inhibitory cholinoesteraz w terapii choroby Alzheimera
Cholinesterase inhibitors in Alzheimer disease therapy
Autorzy:
Zawadzka, A.
Czarnocki, Z.
Powiązania:
https://bibliotekanauki.pl/articles/172066.pdf
Data publikacji:
2015
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
choroba Alzheimera
inhibitory cholinoesteraz
leki hybrydowe
związki o wielokierunkowym działaniu
Alzheimer's disease
cholinesterase inhibitors
hybrid drugs
multi target directed ligands
MTDLs
Opis:
In recent years, a progressive increase in age-related disorders could be observed in most western countries, among which Alzheimer’s disease (AD) is one of the most challenging. The progress of AD is characterized by a severe loss in memory and cognition, leading to behavioral changing, depression and death. Currently approved treatments, including the acetylcholinesterase inhibitors (AChEIs) donepezil, galantamine and rivastigmine and N-methyl-d-aspartate (NMDA) antagonist memantine, do not halt the progression of the disease. The discovering of multifunctional compounds considering that several dual binding site AChEIs were able to reach different targets, guided the development of new drug design strategy, the multi-target-directed ligand (MTDL) approach. This review shows briefly summaries past and present research on the cholinesterase inhibitors (ChIs) able to interact with other targets contributing in aetiology of Alzheimer’s disease.
Źródło:
Wiadomości Chemiczne; 2015, 69, 9-10; 767-788
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Chemiczne aspekty celowanej terapii przeciwnowotworowej I. Kowalencyjne połączenia ligand-nośnik
Chemical as pects of targeted anticancer therapy I. Covalent bond of ligand to carier
Autorzy:
Werengowska, K. M.
Wiśniewski, M.
Terzyk, A.P.
Gurtowska, N.
Drewa, T. A.
Powiązania:
https://bibliotekanauki.pl/articles/171972.pdf
Data publikacji:
2011
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
nanonośniki leków
terapia celowana
ligandy
wiązania kowalencyjne
system dostarczania leków przeciwnowotworowych
nanocarriers of drugs
targeted therapy
ligands
covalent bond
anticancer drug delivery system
Opis:
In this study we describe the most popular biomedical engineering nanoparticles including carbon nanotubes [17-20], liposomes [4-7], polymeric micells [11-13], quantum dots [3, 21-23], hydrogels [24-27], dendrimers [14-16] which are recently considered as modern drug carriers. These nanomaterials are applied for cancer diagnostic and targeted delivery of active compounds as chemotherapeutics in so called targeted therapy. Thus, we characterized the ideas of targeted therapy for which compositions of carriers with antibody are constructed (Figs. 3, 4). We also compared the traditional and targeted mechanisms [1, 3, 28-29] of drug delivery (Fig. 2). During targeted therapy only the essential dose of drug (less than during conventional chemotherapy) is delivering to the cancer cell. In additional, the application of targeted therapy reduces side effects, being very characteristic for the traditional treatment. The anticancer compound can selectively hits the target only, due to the presence of the ligands attached to the surface of nanocarirer. We characterized ligands which are often use in nanomedicine: antibodies [33-37], folic acid [30-33], peptides [33, 38, 39], aptamers [33, 40, 41] and transferrin [33, 42-44]. The purpose of this study is description of the bioconjugation of ligand-nanocarrier. This step is necessary and very important in synthesis of the novel drug delivery systems in targeted anticancer therapy. We report recent advances in the field showing the formation of amides (Figs. 6-8) [51-57], thioethers (Figs. 9-11) [52, 60-66], disulfides (Fig. 12) [69], and acethyl-hydrazone groups (Fig. 13) [73]. Special attention is paid to the process such as Diels-Alder (Figs. 14, 15) [74, 75] and "click chemistry" through the cycloaddition of Huisgen (Figs. 16, 17) [79-82]. We describe also the reaction of Staudinger [83] and the process of formation Schiff 's base [84]. The processes enable very mild and selective modification of the carriers through formation of amide bound. These methods ware less popular but allow the fictionalization of nanocarriers in biomedical application. Each reaction or process needs special and individual environment and conditions, which are summarized in Table 1.
Źródło:
Wiadomości Chemiczne; 2011, 65, 9-10; 887-915
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Zastosowanie związków kompleksowych platyny, palladu i kobaltu w medycynie. Cz. 1
Application of coordination compounds of platinum, palladium and cobalt in medicine. Part 1
Autorzy:
Pawlak, Marta
Drzeżdżon, Joanna
Jacewicz, Dagmara
Powiązania:
https://bibliotekanauki.pl/articles/1409835.pdf
Data publikacji:
2020
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
związki kompleksowe platyny
związki kompleksowe palladu
związki kompleksowe kobaltu
leki przeciwnowotworowe
coordination compounds of platinum
coordination compounds of palladium
coordination compounds of cobalt
anticancer drugs
Opis:
The complex compounds containing metal ions are a group of compounds widely used in medicine. More and more metals are also being used to create cancer drugs or to help with other very serious diseases. Anticancer drugs are a particular use of complex compounds. Many thousands of platinum(II) compounds have been synthesized in cancer therapy, but only six of them have found use in the treatment of cancer. The most popular and the most commonly used compound is cisplatin, it has become the basis for the treatment of bladder, cervical, head, esophagus and many cancers occurring in children. The mechanism of action of platinum(II) and platinum(IV) compounds against cancer cells is to inhibit DNA replication, then RNA transcription and stop the G2 phase of the cell cycle and lead to programmed cell death or apoptosis. Coordination compounds containing more than one metal ion in their composition open new possibilities in the fight against cancer. Pt-DNA connections created by compounds containing at least two metal atoms are different from those formed by cisplatin. The basic dinuclear structure allows for great flexibility in forming DNA-DNA or DNA-protein bonds. The cobalt(III) complexes began to be used to image areas of hypoxia in cancer cells. It is believed, that cobalt(III) complexes undergo bioreduction, which leads to the release of the labile cobalt(II) complex and one or more bioactive ligands. Studies on nitro-Co(III) complexes containing acetylacetone and a nitrogen mustard ligand have shown that it is a particularly effective anti-cancer drug. Due to the fact that many people have cancer new effective anti-cancer drugs with low toxicity and no side effects are still being sought.
Źródło:
Wiadomości Chemiczne; 2020, 74, 11-12; 797-822
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies